Peng Guan Selected Research

Moclobemide (Arima)

1/2021	Improving the precision of modeling the incidence of hemorrhagic fever with renal syndrome in mainland China with an ensemble machine learning approach.
12/2020	Comparison of ARIMA model and XGBoost model for prediction of human brucellosis in mainland China: a time-series study.
5/2019	Time series analysis of human brucellosis in mainland China by using Elman and Jordan recurrent neural networks.
12/2015	[Application of nonlinear autoregressive neural network in predicting incidence tendency of hemorrhagic fever with renal syndrome].
1/2015	Comparison of Two Hybrid Models for Forecasting the Incidence of Hemorrhagic Fever with Renal Syndrome in Jiangsu Province, China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peng Guan Research Topics

Disease

25	Neoplasms (Cancer) 02/2022 - 09/2008
15	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2008
8	Neuroblastoma 02/2022 - 03/2016
6	Hypoxia (Hypoxemia) 06/2020 - 01/2019
4	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 01/2019
4	Adenocarcinoma of Lung 01/2021 - 12/2009
4	Brucellosis (Malta Fever) 12/2020 - 05/2019
4	Heart Failure 01/2018 - 07/2011
3	Body Weight (Weight, Body) 01/2021 - 01/2013
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2019
3	Fibrosis (Cirrhosis) 01/2021 - 03/2017
3	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2021 - 01/2015
3	Iron Overload 06/2020 - 01/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2019 - 01/2013
3	Adenocarcinoma 06/2012 - 04/2002
2	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022 - 12/2015
2	Cardiomyopathies (Cardiomyopathy) 07/2021 - 11/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 02/2016
2	Obstructive Sleep Apnea 06/2020 - 01/2019
2	Carcinoma (Carcinomatosis) 03/2017 - 11/2009
2	Carcinogenesis 03/2017 - 11/2008
2	Anemia 03/2016 - 07/2015
2	Inflammation (Inflammations) 03/2016 - 03/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2010 - 11/2009
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 06/2022
1	Birth Weight (Birth Weights) 06/2022
1	COVID-19 02/2022
1	Infertility (Sterility) 02/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Genetic Risk Score 01/2021
1	Cardiotoxicity 01/2021
1	Hypertrophy 01/2021
1	Rhabdomyosarcoma 10/2020
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2020
1	Sarcoma (Soft Tissue Sarcoma) 10/2020
1	Cognitive Dysfunction 06/2020
1	Infections 02/2020

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 06/2020 - 04/2002
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
5	Moclobemide (Arima)IBA 01/2021 - 01/2015
5	MicroRNAs (MicroRNA)IBA 03/2020 - 06/2012
4	ProdrugsIBA 02/2022 - 01/2018
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 11/2011
4	CytokinesIBA 07/2020 - 01/2014
4	HydrogenIBA 05/2019 - 01/2019
4	IronIBA 03/2019 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 07/2009
3	CamptothecinIBA 02/2022 - 10/2020
3	Antineoplastic Agents (Antineoplastics)IBA 02/2022 - 01/2019
3	Topoisomerase I InhibitorsIBA 02/2022 - 10/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 01/2018
3	Biological ProductsIBA 01/2022 - 03/2015
3	AntioxidantsIBA 01/2021 - 01/2018
3	rho-Associated KinasesIBA 01/2018 - 07/2011
3	fasudil (AT 877)IBA 01/2018 - 07/2011
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2015 - 04/2013
2	Phosphotransferases (Kinase)IBA 05/2021 - 07/2011
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 04/2019
2	Coal (Coals)IBA 01/2021 - 03/2015
2	InterleukinsIBA 07/2020 - 03/2016
2	Monoclonal AntibodiesIBA 07/2020 - 06/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2020 - 01/2019
2	FenretinideIBA 01/2020 - 01/2019
2	entrectinibIBA 01/2020 - 03/2016
2	Lenalidomide (CC 5013)FDA Link 01/2020 - 01/2019
2	AntigensIBA 12/2019 - 04/2015
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2019 - 04/2015
2	LipidsIBA 12/2019 - 01/2019
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2019 - 07/2011
2	NeuroglobinIBA 10/2015 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 06/2006
2	Dextrans (Dextran)FDA Link 07/2015 - 01/2013
2	ORALIT (ORS)IBA 01/2015 - 11/2008
2	arginylarginine (Arg-Arg)IBA 01/2013 - 05/2011
2	SmokeIBA 01/2013 - 12/2009
2	prolyl-proline (Pro-Pro)IBA 01/2013 - 05/2011
2	Codon (Codons)IBA 05/2011 - 10/2009
1	Serine (L-Serine)FDA Link 06/2022
1	SeleniumIBA 06/2022
1	tocolIBA 02/2022
1	Particulate MatterIBA 02/2022
1	Poloxamer (Poloxamer 407)IBA 01/2022
1	Tumor Suppressor Protein p53IBA 01/2022
1	SoilIBA 02/2021
1	4-hydroxybenzylcyanideIBA 02/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	astragaloside AIBA 01/2021
1	PolyphenolsIBA 01/2021
1	PolymersIBA 10/2020
1	Interleukin-12 (IL 12)IBA 07/2020
1	Caspase 3 (Caspase-3)IBA 06/2020
1	huperzine AIBA 06/2020
1	VaccinesIBA 02/2020

Therapy/Procedure

10	Therapeutics 02/2022 - 01/2014
5	Drug Therapy (Chemotherapy) 02/2022 - 12/2009
2	Radiotherapy 08/2010 - 12/2009
1	Immunotherapy 06/2020